Advertisement

Topics

Carrick licenses ovarian cancer project from BTG

15:40 EDT 12 Oct 2018 | Elsevier Business Intelligence

BTG PLC granted Carrick Therapeutics Ltd. exclusive global rights to BTG945 for ovarian cancer. Financial terms were not disc...

Original Article: Carrick licenses ovarian cancer project from BTG

NEXT ARTICLE

More From BioPortfolio on "Carrick licenses ovarian cancer project from BTG"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...